Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Aug 1;13(4):755-756.
doi: 10.21037/hbsn-24-217. Epub 2024 Jul 22.

The validity of serum ferritin levels in predicting cardiovascular events of metabolic dysfunction-associated steatotic liver disease patients may need more consideration

Jie Yang  1   2 , Qing Liu  1   2 , Jie Li #  3 , Chao Sun #  1   2
Affiliations
Comment

The validity of serum ferritin levels in predicting cardiovascular events of metabolic dysfunction-associated steatotic liver disease patients may need more consideration

Jie Yang et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Metabolic dysfunction-associated steatotic liver disease (MASLD); cardiovascular events; serum ferritin.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-217/coif). The authors have no other conflicts of interest to declare.

Comment on

  • Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
    Armandi A, Sanavia T, Younes R, Caviglia GP, Rosso C, Govaere O, Liguori A, Francione P, Gallego-Duràn R, Ampuero J, Pennisi G, Aller R, Tiniakos D, Burt A, David E, Vecchio F, Maggioni M, Cabibi D, McLeod D, Pareja MJ, Zaki MYW, Grieco A, Stål P, Kechagias S, Fracanzani AL, Valenti L, Miele L, Fariselli P, Eslam M, Petta S, Hagström H, George J, Schattenberg JM, Romero-Gómez M, Anstee QM, Bugianesi E. Armandi A, et al. Gut. 2024 Apr 5;73(5):825-834. doi: 10.1136/gutjnl-2023-330815. Gut. 2024. PMID: 38199805

References

    1. Armandi A, Sanavia T, Younes R, et al. Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut 2024;73:825-34. 10.1136/gutjnl-2023-330815 - DOI - PubMed
    1. Liu WY, Lian LY, Zhang H, et al. A Population-Based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia. J Clin Endocrinol Metab 2024;109:1540-9. 10.1210/clinem/dgad749 - DOI - PMC - PubMed
    1. Suresh D, Li A, Miller MJ, et al. Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease. Liver Int 2024;44:389-98. 10.1111/liv.15787 - DOI - PMC - PubMed
    1. Garcia-Casal MN, Peña-Rosas JP, Urrechaga E, et al. Performance and comparability of laboratory methods for measuring ferritin concentrations in human serum or plasma: A systematic review and meta-analysis. PLoS One 2018;13:e0196576. 10.1371/journal.pone.0196576 - DOI - PMC - PubMed
    1. Karakochuk CD, Whitfield KC, Rappaport AI, et al. Comparison of four immunoassays to measure serum ferritin concentrations and iron deficiency prevalence among non-pregnant Cambodian women and Congolese children. Clin Chem Lab Med 2017;55:65-72. 10.1515/cclm-2016-0421 - DOI - PubMed

LinkOut - more resources